Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CORT

"A modern rock machine providing up-to-date tones and plenty of fun features at a reasonable price": Manson Meta MBM-2H Sustainiac review

Produced by Cort, Manson refines the Meta MBM-1 with the updated Meta MBM-2H, perfect for Muse fans or those out for a modern sound

Guitar World

“Every guitar player should have a nylon-string guitar in their collection. This is an ideal‘gateway’ instrument for electric players”: Cort Sunset Nylectric DLX review

Cort's stylish single-cut might be the hybrid nylon-string that electric players are looking for

Guitar World

“This bass has plenty of cutting power, and it's versatile enough to handle just about any gig”: Cort GB-Fusion 4 review

A new entry to the wallet-friendly bassmarket, the Cort GB-Fusion 4 combines impressive pickups and hardware with classic J-Bass style

Guitar World

From analysis to the latest developments in health,
read the most diverse news in one place.

“Beyond its beauty, the cocobolo contributes to the guitar’s overall projection and sustain”: Cort’s stunning new Gold Series acoustic is a love letter to an exotic tone wood

The superlative Gold Series welcomes the A-10 Cocobolo, a high-end grand auditorium cutaway that is all kinds of fancy

MusicRadar

3 Biopharmaceutical Stocks Bucking the Sell-Off

Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.

MarketBeat

"This bass has got a bit of a Goldilocks vibe going on": Cort Artisan Space 4 review

Cort's Space program has expanded with a four-string variant and you might want to get onboard

MusicRadar

“If this guitar had come out of one of our other facilities saying Fender no one would be having this conversation”: Fender’s Justin Norvell on the $599 Standard Series, how it was made, and why it is not a Squier with a different decal on the headstock

Fender’s EVP of product on who its new Indonesian entry-level series is for, what its critics are getting wrong, and why this is (probably) as affordable as the Acoustasonic is going to get

MusicRadar

Read news from The Economist, FT, and more,
with one subscription

“Exceeds in playability, looks, and affordability”: Cort promises the pinnacle of affordable acoustic guitars with its $449 Essence series

Grand Auditorium and OM Cutaway models feature in the all-new vintage-modern electric-acoustic designs

Guitar World

“It’s unique, fast, accurate, and extreme. This is a huge update”: Cort and Hedras continue to elevate their progressive electric design with new Mutility II – and it’s got more tones than ever before

Improved ergonomics and bolstered tonal versatility headline Cort’s latest Hedras-designed drop

Guitar World

“Prized for its warm and rich character”: Cort brings unsung solid cedar to an accessible price point with 2 sleek $370 acoustics

Two new Fishman-loaded builds take a tonewood reserved for premium and nylon-string acoustics to a new budget-friendly price range

Guitar World

“Cedar topped guitars bring warmth and resonance to production models at an attractive price point.”: Solid red cedar tops on a $369 acoustic? Cort unveils a pair of affordable and eye-catching cutaway electros with satin black tops

The handsome cutaway dreadnought and orchestra model acoustics feature solid red cedar on top, mahogany on the back and sides, Fishman electronics – and those ivory pickguards look cool against the black tops

MusicRadar

“Dependability and durability baked in”: Cort takes a leaf out of Strandberg’s book and begins its True Temperament experiments with the KX700 TT

With looks to kill – and tuning and intonation that promises to withstand even the most aggressive of play styles – Cort’s new high-end model drags the innovative fret design to a slightly more accessible price point

Guitar World

“A new level of technical playability and truly musical tone”: Cort expands its shred-ready electric guitar lineup with the KX700 TT, a limited edition high-end S-style with Fishman Fluence humbuckers and True Temperament frets for on-point intonation

Intonation, intonation, intonation... This top-tier electric is for the tuning freaks and players with minds open enough to give the curved-fret True Temperament tech a go

MusicRadar

“Cort really is to be congratulated once again for delivering onits Masterpiece promise”: Cort Abstract Delta and Modern Black review

Two acoustics from Cort’s China-based workshop that couldn’t be further apart in style, from the traditional overtones of the AbstractDelta, to the more contemporary Modern Black

Guitar World

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

James Earl Jones obituary

American actor hailed for his many classical roles whose voice became known to millions as that of Darth Vader in Star Wars

MusicRadar

“A value-conscious workhorse with premium features”: Cort adds the impressively spec’d, competitively priced G250 to its super-versatile G series of S-style electric guitars

Just $349 and you get an HSS bolt-on electric with a roasted maple neck, 2-point tremolo, and Cort's new Voiced Tone pickups with 5-way switching and coil-split

Guitar World

2024 Summer Ultimate Gear Guide: the hottest new guitar gear of the year

A detailed rundown of the hottest guitar gear to hit the market over the past year. Here, we dive into the standout pieces.

Cycling Weekly

Jasper Philipsen outsprints Wout van Aert to win stage 13 of the Tour de France in Pau

Philipsen takes second victory of the race ahead of Van Aert and Pascal Ackermann

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Biotech Stocks With Sky-High Price Targets

The biotech sector is primed for growth, fueled by numerous advancements in genetic engineering and rising investment in research and development of personalized medicine. Hence, quality biotech stocks, BioMarin Pharmaceutical (BMRN), Alnylam Pharmaceuticals (ALNY), and Corcept Therapeutics (CORT) with sky-high price targets might be solid buys. Read more….

StockNews.com

3 Biotech Stocks for Investing in the Future

The biotech sector is primed for robust expansion fueled by the growing needs for personalized medicines and favorable government initiatives. Amid this backdrop, investors could consider buying biotech stocks Esperion Therapeutics (ESPR), Corcept Therapeutics (CORT), and Shionogi (SGIOY). Keep reading.

StockNews.com

3 Promising Biotech Stocks Driving Weekly Gains

The biotech industry’s prospects appear promising due to government support, regulatory changes, innovative therapies, and a focus on personalized medicine. Therefore, investors could consider buying fundamentally strong biotech stocks such as United Therapeutics (UTHR), TRACON Pharmaceuticals (TCON), and Corcept Therapeutics (CORT). Read more.

StockNews.com

Top 3 Biotech Stocks to Anchor Your Portfolio

Amid robust global medicine spending, surging biopharma M&A activity, and technological advancements, the biotech industry is set for significant growth this year and beyond. Given the industry’s bright prospects, top biotech stocks Corcept Therapeutics (CORT), Entrada Therapeutics (TRDA), and Exelixis (EXEL) might be ideal buys now to anchor one’s portfolio.…

Livingetc

5 Easy Changes That Make Your Living Room More Low Maintenance

If keeping up with a tidy, clean living room is keeping you up at night, make these simple switches that will make it easier to reset every day

Guitar World

“It isn’t just a modern headless instrument; it’s a resurrection of a pioneering legacy”: Cort reinvents its “revolutionary” headless Artisan bass design with the upgraded Space 5 model

New five-string model pairs own-brand headless tech with refined sculpting for a compact and tonally balanced build

StockNews.com

Plunge into Profits With These 3 Biotech Stocks

The biotech industry's robust growth potential is driven by substantial pharma research and development, swift technological advancements, and lucrative government support. Given this backdrop, quality biotech stocks ProQR Therapeutics N.V. (PRQR), Regeneron Pharmaceuticals (REGN), and Corcept Therapeutics (CORT) could be solid buys now. Read on….

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Regeneron Pharmaceuticals

84 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.